Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.23736/S2724-6051.22.04948-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Editorial Comment on Efficacy of Docetaxel Addition to Next-Generation Androgen Receptor-Axis-Targeted Therapies and Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer: A Tumor Volume-Specific Analysis.
Int J Urol
September 2025
Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Japan.
Ketone supplementation acutely lowers androgen and glucose levels in women with polycystic ovary syndrome: a randomized clinical trial.
Eur J Endocrinol
July 2025
Division of Gastroenterohepatology, Department of Internal Medicine, Istanbul University, Faculty of Medicine, Istanbul 34096, Turkey.
Reply: Ketone supplementation acutely lowers androgen and glucose levels in women with polycystic ovary syndrome: a randomized clinical trial.
Eur J Endocrinol
July 2025
Department of Endocrinology, Aarhus University Hospital, 8200 Aarhus N, Denmark.
Tumor heterogeneity in metastatic prostate cancer (mPC) is well established, but comprehensive characterization using routine sampling remains challenging. Autopsy-based research addresses this obstacle by enabling broad tissue collection within individual patients after treatment. In this issue of the JCI, Roudier et al.
View Article and Find Full Text PDFAdvances in genomic biomarkers for lethal metastatic castration-resistant prostate cancer.
Transl Cancer Res
June 2025
Division of Hematology/Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA.